vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion to treat cystic fibrosis related diabetes; HPP3033, a non-electrophilic therapeutic approach to activating the Nrf2 pathway for the treatment of chronic diseases associated with oxidative stress; azeliragon, a RAGE antagonist for inflammatory lung diseases, including severe COVID-19, as well as for pancreatic and breast cancers; and HPP971, an Nrf2 activator for renal diseases through partnerships with pharmaceutical partners. The company has a license agreement with Reneo Pharmaceuticals, Inc. to develop and commercialize peroxisome proliferation activated receptor delta agonist program, including the compound HPP593. vTv Therapeutics Inc. also has license and research agreements with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.; Newsoara Biopharma Co., Ltd.; JDRF International; and Novo Nordisk A/S. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Incorporated. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of vTv Therapeutics Inc..
vTv Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of vTv Therapeutics Inc. are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of vTv Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of vTv Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of vTv Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of vTv Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 vTv Therapeutics Inc.- Key Facts
2.2 vTv Therapeutics Inc.- Geographic Locations
2.3 vTv Therapeutics Inc.- Subsidiaries and Affiliates
2.4 vTv Therapeutics Inc.- Business Divisions
2.5 vTv Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. vTv Therapeutics Inc. Strategic Analysis Review
3.1 vTv Therapeutics Inc.- Key Strategies
3.2 vTv Therapeutics Inc.- Company Outlook Statement
3.3 vTv Therapeutics Inc.- SWOT Analysis
3.3.1 vTv Therapeutics Inc.- Key Strengths
3.3.2 vTv Therapeutics Inc.- Key Weaknesses
3.3.3 vTv Therapeutics Inc.- Potential Opportunities
3.3.4 vTv Therapeutics Inc.- Potential Threats
3.4 vTv Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 vTv Therapeutics Inc.- Business Overview
4.2 vTv Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 vTv Therapeutics Inc.- Key Products
5.2 vTv Therapeutics Inc.- Key Service Areas
5.3 vTv Therapeutics Inc.- Key Brands
6 Company Developments
6.1 vTv Therapeutics Inc.- Company History
6.2 vTv Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 vTv Therapeutics Inc.- Income Statements
7.2 vTv Therapeutics Inc.- Balance Sheet
7.3 vTv Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 vTv Therapeutics Inc.- Direct Competitors
8.2 vTv Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 vTv Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 vTv Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!